Strikingly, OLA1 expression positively correlated with IMP2 and ZFAS1 in CRC cells and tissues, which indicated that these indicators may be potential diagnostic and novel therapeutic strategies for CRC treatment. This evidence concerns the gene OLA1 and colorectal carcinoma.